Cargando…
Atorvastatin treatment improves effects of implanted mesenchymal stem cells: meta-analysis of animal models with acute myocardial infarction
BACKGROUND: Previous studies reported that Atorvastatin (ATOR) can improve the efficacy of Mesenchymal stem cells (MSCs) transplantation after acute myocardial infarction (AMI). However, the results of those studies were inconsistent. To clarify the beneficial effects of atorvastatin added to the ce...
Autores principales: | Dai, Guo, Xu, Qing, Luo, Rong, Gao, Jianfang, Chen, Hui, Deng, Yun, Li, Yongqing, Wang, Yuequn, Yuan, Wuzhou, Wu, Xiushan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678482/ https://www.ncbi.nlm.nih.gov/pubmed/26667804 http://dx.doi.org/10.1186/s12872-015-0162-6 |
Ejemplares similares
-
Optimization of Timing and Times for Administration of Atorvastatin‐Pretreated Mesenchymal Stem Cells in a Preclinical Model of Acute Myocardial Infarction
por: Xu, Jun, et al.
Publicado: (2019) -
SMYD1, an SRF-Interacting Partner, Is Involved in Angiogenesis
por: Ye, Xiangli, et al.
Publicado: (2016) -
asb5a/asb5b Double Knockout Affects Zebrafish Cardiac Contractile Function
por: Cai, Wanwan, et al.
Publicado: (2023) -
Dose-dependent effects of atorvastatin on myocardial infarction
por: Barbarash, Olga, et al.
Publicado: (2015) -
The Influence of Angiotensin Converting Enzyme and Angiotensinogen Gene Polymorphisms on Hypertrophic Cardiomyopathy
por: Luo, Rong, et al.
Publicado: (2013)